DK2603513T3 - Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator - Google Patents

Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator Download PDF

Info

Publication number
DK2603513T3
DK2603513T3 DK11749944.2T DK11749944T DK2603513T3 DK 2603513 T3 DK2603513 T3 DK 2603513T3 DK 11749944 T DK11749944 T DK 11749944T DK 2603513 T3 DK2603513 T3 DK 2603513T3
Authority
DK
Denmark
Prior art keywords
heterocyclic compound
positive allosteric
receptor positive
ampa receptor
allosteric modulator
Prior art date
Application number
DK11749944.2T
Other languages
Danish (da)
English (en)
Inventor
Masakuni Kori
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Michiyo Mochizuki
Toshihiro Imaeda
Osamu Ujikawa
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Application granted granted Critical
Publication of DK2603513T3 publication Critical patent/DK2603513T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK11749944.2T 2010-08-10 2011-08-09 Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator DK2603513T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (1)

Publication Number Publication Date
DK2603513T3 true DK2603513T3 (da) 2020-06-15

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11749944.2T DK2603513T3 (da) 2010-08-10 2011-08-09 Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator

Country Status (39)

Country Link
US (11) US8575154B2 (enExample)
EP (1) EP2603513B1 (enExample)
JP (2) JP5788496B2 (enExample)
KR (1) KR101852215B1 (enExample)
CN (2) CN104926837A (enExample)
AR (1) AR082618A1 (enExample)
AU (1) AU2011290126B2 (enExample)
BR (1) BR112013002250B1 (enExample)
CA (1) CA2807460C (enExample)
CL (1) CL2013000380A1 (enExample)
CO (1) CO6680700A2 (enExample)
CR (1) CR20130066A (enExample)
CY (1) CY1123507T1 (enExample)
DK (1) DK2603513T3 (enExample)
DO (1) DOP2013000030A (enExample)
EA (1) EA022078B1 (enExample)
EC (1) ECSP13012478A (enExample)
ES (1) ES2793723T3 (enExample)
GE (1) GEP20156216B (enExample)
HR (1) HRP20200844T1 (enExample)
HU (1) HUE049460T2 (enExample)
IL (1) IL224452A (enExample)
LT (1) LT2603513T (enExample)
MA (1) MA34509B1 (enExample)
MX (1) MX349470B (enExample)
MY (1) MY165908A (enExample)
NZ (1) NZ607593A (enExample)
PE (1) PE20131116A1 (enExample)
PH (1) PH12013500247A1 (enExample)
PL (1) PL2603513T3 (enExample)
PT (1) PT2603513T (enExample)
RS (1) RS60311B1 (enExample)
SG (1) SG187656A1 (enExample)
SI (1) SI2603513T1 (enExample)
TW (1) TWI504604B (enExample)
UA (1) UA111594C2 (enExample)
UY (1) UY33551A (enExample)
WO (1) WO2012020848A1 (enExample)
ZA (1) ZA201301120B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022078B1 (ru) * 2010-08-10 2015-10-30 Такеда Фармасьютикал Компани Лимитед Гетероциклическое соединение и его применение
JP5976011B2 (ja) * 2011-04-05 2016-08-23 武田薬品工業株式会社 スルホンアミド誘導体およびその用途
JP6134654B2 (ja) * 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
CA2915405A1 (en) * 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
CA2916653C (en) 2013-06-27 2017-07-18 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
MX2016007259A (es) 2013-12-03 2016-08-04 Du Pont Pirrolidinonas como herbicidas.
AU2015284280C1 (en) 2014-07-02 2020-02-13 Fmc Corporation Piperidinone herbicides
JP6611816B2 (ja) 2014-12-08 2019-11-27 エフ エム シー コーポレーション 3−オキソ−3−(アリールアミノ)プロパノエイト、その製造方法、およびピロリジノンの製造におけるその使用
JP6956637B2 (ja) 2015-04-10 2021-11-02 エフ エム シー コーポレーションFmc Corporation 除草剤としての置換環状アミド
CN107531658B (zh) 2015-04-27 2021-07-27 Fmc公司 作为除草剂的丁内酯
ES2865330T3 (es) * 2015-04-29 2021-10-15 Janssen Pharmaceutica Nv Azabenzimidazoles y su uso como moduladores del receptor AMPA
JP6800885B2 (ja) * 2015-04-29 2020-12-16 ヤンセン ファーマシューティカ エヌ.ベー. イミダゾピラジン及びピラゾロピリミジン、並びにampa受容体調節物質としてのこれらの使用
AU2016259529B2 (en) 2015-05-12 2020-10-01 Fmc Corporation Aryl substituted bicyclic compounds as herbicides
US10906873B2 (en) 2015-05-29 2021-02-02 Fmc Corporation Substituted cyclic amides as herbicides
JP6949730B2 (ja) 2015-06-02 2021-10-13 エフ エム シー コーポレーションFmc Corporation 置換環状アミドおよび除草剤としてのそれらの使用
CN108137512B (zh) 2015-07-31 2022-05-31 Fmc公司 用作除草剂的环状n-酰胺化合物
PL3331892T3 (pl) * 2015-08-06 2019-11-29 Hoffmann La Roche Sposób wytwarzania pochodnych kwasu GalNAc
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
ES2958741T3 (es) 2016-12-21 2024-02-14 Fmc Corp Herbicidas de nitrona
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
AU2018239940B2 (en) 2017-03-21 2023-12-07 Fmc Corporation Herbicidal mixture, composition and method
SG11201908640TA (en) 2017-03-21 2019-10-30 Fmc Corp Pyrrolidinones and a process to prepare them
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
JP7250686B2 (ja) * 2017-10-06 2023-04-03 武田薬品工業株式会社 複素環化合物
US11447488B2 (en) 2017-10-06 2022-09-20 Takeda Pharmaceutical Company Limited Heterocyclic compounds
CR20220160A (es) 2019-09-16 2022-06-16 Takeda Pharmaceuticals Co Derivados de piridazin-3(2h)-ona fusionados con azol
WO2021229294A1 (en) * 2020-05-15 2021-11-18 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025226591A1 (en) 2024-04-22 2025-10-30 Neurocrine Biosciences, Inc. Methods of administering 9-[4-(cyclohexyloxy)phenyl]-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide without side effects

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (enExample) 1986-10-22 1992-09-04
JPH0285851A (ja) 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
EP1229786A1 (en) 1999-11-04 2002-08-14 Colorado State University Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1275951C (zh) * 2001-10-10 2006-09-20 神经研究公司 新的苯并噻嗪衍生物、其制备和应用
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0713529A2 (pt) 2006-06-23 2012-04-17 Nufarm Australia Ltd composição herbicida de fenóxi alcanoato e método de preparação e uso
EA015600B1 (ru) * 2006-12-11 2011-10-31 Эли Лилли Энд Компани Агенты, усиливающие действие амра-рецепторов
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
WO2009061699A1 (en) 2007-11-05 2009-05-14 Schering Corporation Gamma secretase modulators
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
JPWO2009119088A1 (ja) 2008-03-25 2011-07-21 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
AU2009313527A1 (en) * 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
WO2011007756A1 (ja) 2009-07-13 2011-01-20 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
EA022078B1 (ru) * 2010-08-10 2015-10-30 Такеда Фармасьютикал Компани Лимитед Гетероциклическое соединение и его применение

Also Published As

Publication number Publication date
US20150353578A1 (en) 2015-12-10
US20180162875A1 (en) 2018-06-14
KR20130138738A (ko) 2013-12-19
CR20130066A (es) 2013-05-03
US20200317692A1 (en) 2020-10-08
AU2011290126B2 (en) 2016-01-07
BR112013002250B1 (pt) 2020-10-27
CN103180326A (zh) 2013-06-26
EA201390222A1 (ru) 2013-08-30
US9884875B2 (en) 2018-02-06
PT2603513T (pt) 2020-06-08
CA2807460A1 (en) 2012-02-16
US20140080817A1 (en) 2014-03-20
BR112013002250A2 (pt) 2016-05-24
MX2013001614A (es) 2013-07-05
ES2793723T3 (es) 2020-11-16
WO2012020848A8 (en) 2012-09-27
US20130190291A1 (en) 2013-07-25
US11279713B2 (en) 2022-03-22
UY33551A (es) 2012-03-30
CO6680700A2 (es) 2013-05-31
RS60311B1 (sr) 2020-07-31
ZA201301120B (en) 2014-04-30
EP2603513A1 (en) 2013-06-19
MA34509B1 (fr) 2013-09-02
CN103180326B (zh) 2015-06-10
IL224452A (en) 2017-11-30
US8916551B2 (en) 2014-12-23
US8575154B2 (en) 2013-11-05
JP2013535408A (ja) 2013-09-12
JP5788496B2 (ja) 2015-09-30
CY1123507T1 (el) 2022-03-24
TWI504604B (zh) 2015-10-21
JP2016006080A (ja) 2016-01-14
US20240360156A1 (en) 2024-10-31
AU2011290126A1 (en) 2013-03-07
PE20131116A1 (es) 2013-10-24
CA2807460C (en) 2018-09-18
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
US9499568B2 (en) 2016-11-22
US20130184266A1 (en) 2013-07-18
LT2603513T (lt) 2020-05-25
US20150073137A1 (en) 2015-03-12
JP6113789B2 (ja) 2017-04-12
US20170022222A1 (en) 2017-01-26
MY165908A (en) 2018-05-18
US8778934B2 (en) 2014-07-15
GEP20156216B (en) 2015-01-12
US10654874B2 (en) 2020-05-19
HRP20200844T1 (hr) 2020-08-21
NZ607593A (en) 2015-01-30
US20190263832A1 (en) 2019-08-29
PL2603513T3 (pl) 2020-07-27
CL2013000380A1 (es) 2013-05-31
WO2012020848A1 (en) 2012-02-16
US9150591B2 (en) 2015-10-06
MX349470B (es) 2017-07-31
HUE049460T2 (hu) 2020-09-28
AR082618A1 (es) 2012-12-19
EA022078B1 (ru) 2015-10-30
DOP2013000030A (es) 2013-03-15
US20120077799A1 (en) 2012-03-29
EP2603513B1 (en) 2020-03-11
TW201217386A (en) 2012-05-01
CN104926837A (zh) 2015-09-23
PH12013500247A1 (en) 2013-03-11
SG187656A1 (en) 2013-03-28
KR101852215B1 (ko) 2018-04-25
ECSP13012478A (es) 2013-04-30

Similar Documents

Publication Publication Date Title
DK2603513T3 (da) Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator
DK2389382T3 (da) Aminoheterocykliske forbindelser anvendt som pde9-inhibitorer
DK2542528T3 (da) Heterocykliske amider som rock-inhibitorer
DK2540728T3 (da) Heterocyklisk forbindelse
DK2406253T3 (da) Benzofuranylderivater anvendt som glucokinase-inhibitorer
DK2594567T3 (da) Heterocykliske alkynylbenzenforbindelser og anvendelser deraf
EP2579717A4 (en) POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
EP2603079A4 (en) POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
PL2593452T3 (pl) Związki heterocykliczne będące agonistami receptora IP
EP2542083A4 (en) POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
FI20095678A0 (fi) Ureasubstituoituja sulfoniamidijohdannaisia
DK3178818T3 (da) Pyrazolylquinoxalinkinasehæmmere
DK2590974T3 (da) Tetrahydropyridopyrimidinderivater
EP2604601A4 (en) HETERO RING CONNECTION
EP2501231A4 (en) POSITIVE ALLOSTERIC CHINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR MODULATORS
EP2490692A4 (en) CHINOLINONE PYRAZOLON M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
EP2624697A4 (en) POSITIVE ALLOSTERIC DIHYDROBENZOCHINAZOLINONE M1 RECEPTOR MODULATORS
EP2512245A4 (en) POSITIVE ALLOSTERIC PYRIDOCHINOLICIDIDINE M1 RECEPTOR MODULATORS
EP2473048A4 (en) POSITIVE PYRANYL-ARYL-METHYL-BENZOCHINAZOLINONE ALLOSTERIC M1 RECEPTOR MODULATORS
DK3070091T3 (da) Benzodioxolderivater som phosphodiesterasehæmmere
DK2513106T3 (da) Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer
IL231783A0 (en) History of ethinyl as allosteric modulators of 5mglur
BR112013010643A2 (pt) compostos heterocíclicos
SI2702051T1 (sl) Etinilni derivati kot pozitivni alosteriäśni modulatorji mglur5
EP2563126A4 (en) HETEROCYCLIC POSITIVE ALLOSTERE M1 RECEPTOR MODULATORS DERIVED FROM CHINOLICINE